Literature DB >> 22609476

Changed phagocytic activity and pattern of Fcγ and complement receptors on blood monocytes in sarcoidosis.

Anna Dubaniewicz1, Marlena Typiak, Monika Wybieralska, Marta Szadurska, Szymon Nowakowski, Agnieszka Staniewicz-Panasik, Katarzyna Rogoza, Adam Sternau, Peter Deeg, Piotr Trzonkowski.   

Abstract

We have recently revealed that mycobacterial heat shock proteins (Mtb-hsp), involved in forming of immune complexes (CIs), can induce immune response in sarcoidosis (SA). The complexemia may result from inappropriate phagocytosis and clearance of CIs by monocytes with following persistent antigenemia and granuloma formation. Because an aberrant expression of receptors for Fc fragment of immunoglobulin G (FcγR) and complement receptors (CR) on monocytes can be involved in this process, we have evaluated the expression of FcγRI (CD64), FcγRII (CD32), FcγRIII (CD16) and CR1 (CD35), CR3 (CD11b), CR4 (CD11c) receptors on blood CD14(+) monocytes and its phagocytic activity in 24 patients with SA and 20 healthy volunteers using flow cytometry. We found significantly increased expression of all examined FcγR and decreased expression of CD35 and CD11c on CD14(+) monocytes in SA patients vs controls. Significantly increased percentage of CD14(+)CD16(+)CD35(-), CD14(+)CD64(+)CD35(+), CD14(+)CD64(+)CD11b(+), CD14(+)CD64(+)CD11c(+) and decreased of CD14(+)CD32(-)CD35(+), CD14(+)CD32(-)CD11b(+), CD14(+)CD32(-)CD11c(+) monocytes' phenotypes was revealed in SA. The total number and percentage of phagocyting monocytes was significantly increased in SA as compared with controls. In conclusion, altered expression of FcγR and CR on CD14(+) monocytes and its increased phagocytic activity may be responsible for high antigen load, persistent antigenemia and immunocomplexemia in SA patients.
Copyright © 2012 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22609476     DOI: 10.1016/j.humimm.2012.05.005

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  13 in total

1.  High mobility group box 1 protein in bronchoalveolar lavage fluid and correlation with other inflammatory markers in pulmonary diseases.

Authors:  Magda Suchankova; Vladimira Durmanova; Elena Tibenska; Eva Tedlova; Ivan Majer; Helena Novosadova; Juraj Demian; Miroslav Tedla; Maria Bucova
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2018-04-28       Impact factor: 0.670

2.  A Novel In Vitro Human Granuloma Model of Sarcoidosis and Latent Tuberculosis Infection.

Authors:  Elliott D Crouser; Peter White; Evelyn Guirado Caceres; Mark W Julian; Audrey C Papp; Landon W Locke; Wolfgang Sadee; Larry S Schlesinger
Journal:  Am J Respir Cell Mol Biol       Date:  2017-10       Impact factor: 6.914

3.  Parallel Gene Expression Changes in Sarcoidosis Involving the Lacrimal Gland, Orbital Tissue, or Blood.

Authors:  James T Rosenbaum; Dongseok Choi; David J Wilson; Hans E Grossniklaus; Christina A Harrington; Cailin H Sibley; Roger A Dailey; John D Ng; Eric A Steele; Craig N Czyz; Jill A Foster; David Tse; Chris Alabiad; Sander Dubovy; Prashant Parekh; Gerald J Harris; Michael Kazim; Payal Patel; Valerie White; Peter Dolman; Bobby S Korn; Don Kikkawa; Deepak P Edward; Hind Alkatan; Hailah Al-Hussain; R Patrick Yeatts; Dinesh Selva; Patrick Stauffer; Stephen R Planck
Journal:  JAMA Ophthalmol       Date:  2015-07       Impact factor: 7.389

Review 4.  Innate and Adaptive Immunity in Noninfectious Granulomatous Lung Disease.

Authors:  Amy S McKee; Shaikh M Atif; Michael T Falta; Andrew P Fontenot
Journal:  J Immunol       Date:  2022-04-15       Impact factor: 5.426

5.  Therapeutic granulocyte and monocyte apheresis (GMA) for treatment refractory sarcoidosis: a pilot study of clinical effects and possible mechanisms of action.

Authors:  H H Olsen; V Muratov; K Cederlund; J Lundahl; A Eklund; J Grunewald
Journal:  Clin Exp Immunol       Date:  2014-09       Impact factor: 4.330

6.  Malaria inhibits surface expression of complement receptor 1 in monocytes/macrophages, causing decreased immune complex internalization.

Authors:  Cristina Fernandez-Arias; Jean Pierre Lopez; Jean Nikolae Hernandez-Perez; Maria Dolores Bautista-Ojeda; Oralee Branch; Ana Rodriguez
Journal:  J Immunol       Date:  2013-02-25       Impact factor: 5.422

7.  FCGR3A and FCGR3B copy number variations are risk factors for sarcoidosis.

Authors:  Jianming Wu; Yunfang Li; Weihua Guan; Kevin Viken; David M Perlman; Maneesh Bhargava
Journal:  Hum Genet       Date:  2016-04-08       Impact factor: 5.881

8.  Involvement of Monocyte Subsets in the Immunopathology of Giant Cell Arteritis.

Authors:  Yannick van Sleen; Qi Wang; Kornelis S M van der Geest; Johanna Westra; Wayel H Abdulahad; Peter Heeringa; Annemieke M H Boots; Elisabeth Brouwer
Journal:  Sci Rep       Date:  2017-07-26       Impact factor: 4.379

9.  Copy number variation of FCGR genes in etiopathogenesis of sarcoidosis.

Authors:  Marlena Typiak; Krzysztof Rębała; Agnieszka Haraś; Monika Skotarczak; Jan Marek Słomiński; Anna Dubaniewicz
Journal:  PLoS One       Date:  2017-05-04       Impact factor: 3.240

Review 10.  The Potential Role of Trained Immunity in Autoimmune and Autoinflammatory Disorders.

Authors:  Rob J W Arts; Leo A B Joosten; Mihai G Netea
Journal:  Front Immunol       Date:  2018-02-20       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.